10 Services from clinicalintelpulse.vercel.app

Finds actively recruiting clinical trials for a disease with plain-language summaries, accessible eligibility criteria, contact info, and application guidance drawn from 400,000+ ClinicalTrials.gov studies

Returns a broad-sweep analysis of all active Phase 2/3 clinical trials for any disease worldwide, including trial count, sponsor landscape, geographic distribution, and pipeline density across 400,000+ trials.

Returns historical Phase 2/3 failure mode analysis for a disease area, covering patient selection, endpoint design, mechanism, dosing, and safety failures with phase transition success rates.

Full pipeline analysis for a pharma or biotech company — trial counts by phase, therapeutic-area coverage, FDA history, partnerships, and competitive positioning.

Returns a comprehensive deep-dive on a specific clinical trial by NCT ID, including full study design, endpoints, enrollment status, sponsor, eligibility criteria, and publications.

Returns the molecular target and mechanism-of-action landscape for a disease, including targets in active trials, approved agents by MOA, crowded vs. novel spaces, and first-in-class openings.

Returns a complete pipeline intelligence snapshot for any disease area, covering Phase 2-3 trial map, mechanism coverage, approved therapies, PDUFA calendar, competitive gaps, and market dynamics.

Returns international clinical trial geographic distribution across WHO ICTRP registries (US, EU, China, India, Japan, Brazil and more), highlighting access gaps and unmet need for any disease area

Analyzes FDA/EMA approval probability for drugs in a given disease area, ranking candidates most likely to win approval in 12–18 months based on Phase 3 data, PDUFA dates, and historical trial success rates.

Returns M&A and licensing deal signals for Phase 2/3 clinical assets, including acquisition probability scores, deal comps, and transaction multiples for a given disease or asset.